We evaluated serial enzyme and bilirubin determinations as aids to diagnosis of Epstein-Barr virus-induced infectious mononucleosis (121 cases) and the heterophil-negative mononucleosis-like illness due to cytomegalovirus (33 cases). Laboratory evidence for either type of mononucleosis includes mild to moderate hepatic dysfunction, with aspartate aminotransferase activity increased, but lower than commonly encountered in active viral hepatitis.
We evaluated serial enzyme and bilirubin determinations as aids to diagnosis of Epstein-Barr virus-induced infectious mononucleosis (121 cases) and the heterophil-negative mononucleosis-like illness due to cytomegalovirus (33 cases). Laboratory evidence for either type of mononucleosis includes mild to moderate hepatic dysfunction, with aspartate aminotransferase activity increased, but lower than commonly encountered in active viral hepatitis.
Of the enzymes commonly assayed in evaluating liver function, aspartate aminotransferase activity was the most commonly abnormal: in 96.7% of those with Epstein-Barr virus disease and 87.9% with cytomegalovirus disease. Values for alkaline phosphatase were increased in 94.2% of the Epstein-Barr virus cases and 63.6% of the cytomegalovirus cases, and y-glutamyltransferase values were increased in 90.9% and 75.8%, respectively. We conclude that, in serially studied patients, normal results for liver-function studies or very high aspartate aminotransferase activities (>1000 U/L) eliminate, for practical purposes, both Epstein-Barr virus and cytomegalovirus as diagnostic considerations.
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Most cases of Epstein-Barr(EBV)-or cytomegalovirus(CMV)-induced mononucleosis exhibit some degree of hepatic dysfunction that is best reflected by increases in the activities of certain serum enzymes-e.g., aspartate aminotransferase (AST) (1_6) . 1 Failure to demonstrate increased serum enzyme activity throughout the course of a mononucleosis-like illness militates strongly against that being the correct diagnosis.
Here, we assess the value of serial enzyme and bilirubin determinations for the diagnosis of EBV-or CMV-induced mononucleosis.
We compare results of serial (i.e., repeated) testing of hepatic function and discuss their clinical usefulness.
Materials and Methods

Procedures
We determined values for AST, AP, LDH, and bilirubin in serum by continuous-flow analysis (SMA-12/60;  Technicon  Instruments Corp., Tarrytown, NY 10591). GGT activity in serum was determined by the method of Szasz (7) 
Results
The highest AST, AP, and GGT activities relative to peak bilirubin values in both EBV-and CMV-induced mononucleosis are depicted in Figures 
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Pk B<I<,cb,n Five of these eight patients also had GGT activities that were within the reference interval. In four patients, initial hepatic studies were not made until 14 to as late as 29 days after the onset of their initial symptoms.
Overall, the initial samples were received on the average 9.8 days after onset from the EBV patients and 10.9 days from the CMV patients.
Of We obtained further insight into the sequence of enzyme and bilirubin alterations from analysis of 579 sera from serial EBV-induced and 112 sera from CM V-induced mononucleosis. AST, AP, and bilirubin values were greatest four to 13 days after onset of illness in EBV-mononucleosis;
GGT activity peaked between four and 18 days after onset. In CMV-mononucleosis, AST, AP and bilirubin activity was greatest seven to 13 days after onset, GGT peaked at 9-22 days.
Serum LDH activity was abnormally high at some time in all but two of the 121 patients with EBV-induced disease and in all but one of 33 with CMV-mononucleosis.
On several occasions, initial LDH activities were abnormal-often exceeding 300 U/L-at a time when AST, GGT, and AP activities were normal; in most cases, these three increased during the second or third week.
With rare exceptions, values for AST and AP activities fell within reference limits by 90 days following onset of disease. Nevertheless, abnormal GGT activities occasionally persisted for various periods up to 12 months after onset of symptoms. The cause of such persistently increased GGT activity after either EBV-or CMV-induced mononucleosis is not known; it could not be related to either chronic hepatic disease or to any other underlying pathology (9) .
Discussion
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during the second or third week of the illness (4). Most peak values were between 41 and 199 U/L (32/47); the highest value they observed was 480 U/L. Rosalki et al. (6) Liver-function studies can never replace viral diagnostic tests for the determination of the causative agent in a particular heterophil-negative infectious mononucleosis-like illness. But when the results of serial hepatic function testing are normal, the diagnosis of EBV-or CMV-induced mononucleosis can, for practical purposes, be excluded. On the other hand, when the results indicate markedly increased AST activity-particularly over 1000 U/L-for practical purposes, again, EBV-and CMV-induced disease are excluded and some other diagnosis, such as active viral hepatitis, should be considered.
Note added in proof:
We have recently evaluated an acutely ill 46-year-old woman with heterophil-positive infectious mononucleosis. Her highest AST activity was 1015 U/L, and peak bilirubin was 11 mg/L.A short course of prednisone therapy was administered because of the severity of her illness.
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